122 related articles for article (PubMed ID: 19176998)
1. Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities.
Kass EM; Poyurovsky MV; Zhu Y; Prives C
Cell Cycle; 2009 Feb; 8(3):430-7. PubMed ID: 19176998
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
[TBL] [Abstract][Full Text] [Related]
3. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
4. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
[TBL] [Abstract][Full Text] [Related]
5. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.
Fu W; Ma Q; Chen L; Li P; Zhang M; Ramamoorthy S; Nawaz Z; Shimojima T; Wang H; Yang Y; Shen Z; Zhang Y; Zhang X; Nicosia SV; Zhang Y; Pledger JW; Chen J; Bai W
J Biol Chem; 2009 May; 284(21):13987-4000. PubMed ID: 19321440
[TBL] [Abstract][Full Text] [Related]
6. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
7. The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover.
Bohgaki M; Hakem A; Halaby MJ; Bohgaki T; Li Q; Bissey PA; Shloush J; Kislinger T; Sanchez O; Sheng Y; Hakem R
Cell Death Differ; 2013 Jun; 20(6):812-22. PubMed ID: 23449389
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
Yang L; Song T; Cheng Q; Chen L; Chen J
Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
[TBL] [Abstract][Full Text] [Related]
9. CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.
García-Limones C; Lara-Chica M; Jiménez-Jiménez C; Pérez M; Moreno P; Muñoz E; Calzado MA
Oncogene; 2016 Aug; 35(33):4289-301. PubMed ID: 26751770
[TBL] [Abstract][Full Text] [Related]
10. Occam's dull razor: MDM2 and P/CAF keep Chk2 in check the hard way.
Grossman SR
Cell Cycle; 2009 Feb; 8(4):515. PubMed ID: 19221470
[No Abstract] [Full Text] [Related]
11. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
[TBL] [Abstract][Full Text] [Related]
12. MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function.
Wu H; Leng RP
Oncotarget; 2015 Aug; 6(25):21479-92. PubMed ID: 26025930
[TBL] [Abstract][Full Text] [Related]
13. SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.
Lu YF; Xu XP; Lu XP; Zhu Q; Liu G; Bao YT; Wen H; Li YL; Gu W; Zhu WG
Oncogene; 2020 Jun; 39(24):4650-4665. PubMed ID: 32404984
[TBL] [Abstract][Full Text] [Related]
14. MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity.
Chinnam M; Xu C; Lama R; Zhang X; Cedeno CD; Wang Y; Stablewski AB; Goodrich DW; Wang X
PLoS Genet; 2022 May; 18(5):e1010171. PubMed ID: 35588102
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of GCN5 PCAF N-terminal domain reveals atypical ubiquitin ligase structure.
Toma-Fukai S; Hibi R; Naganuma T; Sakai M; Saijo S; Shimizu N; Matsumoto M; Shimizu T
J Biol Chem; 2020 Oct; 295(43):14630-14639. PubMed ID: 32820047
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379.
Lovly CM; Yan L; Ryan CE; Takada S; Piwnica-Worms H
Mol Cell Biol; 2008 Oct; 28(19):5874-85. PubMed ID: 18644861
[TBL] [Abstract][Full Text] [Related]
17. MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity.
He Y; Lian G; Lin S; Ye Z; Li Q
PLoS One; 2013; 8(6):e67529. PubMed ID: 23826318
[TBL] [Abstract][Full Text] [Related]
18. The anaphase-promoting complex/cyclosome is an E3 ubiquitin ligase for Mdm2.
He Y; Tollini L; Kim TH; Itahana Y; Zhang Y
Cell Cycle; 2014; 13(13):2101-9. PubMed ID: 24804778
[TBL] [Abstract][Full Text] [Related]
19. MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation.
Chen G; Huang H; Fröhlich O; Yang Y; Klein JD; Price SR; Sands JM
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1528-34. PubMed ID: 18784257
[TBL] [Abstract][Full Text] [Related]
20. AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70.
Centrone M; Ranieri M; Di Mise A; Berlingerio SP; Russo A; Deen PMT; Staub O; Valenti G; Tamma G
Cell Physiol Biochem; 2017; 44(2):515-531. PubMed ID: 29145196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
